Pharmaceutical Technology

AUGUST 4, 2022

Soaring patient numbers are stretching hospital capacity across the globe, forcing healthcare providers and their partners to think laterally about how to meet the demand without doubling their resources. Smarter diagnostic tools and more sophisticated remote- and self-care models will have an increasingly important role to play, as long as any advances are seen to deliver excellent outcomes and a better patient experience.

Healthcare Provider 143

Healthcare Provider Pharma Consulting Healthcare 143

MedCity News

AUGUST 4, 2022

Obtaining an understanding of how specific SDOH factors affect individuals is extremely difficult because SDOH data is not methodically collected by clinicians.

121

121

Pharmaceutical Technology

AUGUST 4, 2022

North America extended its dominance for machine learning hiring among pharmaceutical industry companies in the three months ending May. The number of roles in North America made up 63.9% of total machine learning jobs - up from 62.6% in the same quarter last year. That was followed by Europe, which saw a 0.6 year-on-year percentage point change in machine learning roles.

Pharmaceutical 105

Pharmaceutical Leads Marketing 105

MedCity News

AUGUST 4, 2022

FlipMD recently launched a recruiting platform designed to help healthcare providers, drugmakers and digital health companies find qualified physicians to fill a variety of roles — whether they’re clinical, nonclinical, full time or part time. Physicians on flipMD’s platform can also get paid to refer qualified candidates for positions.

Physicians 110

Physicians Healthcare Provider Recruitment Healthcare 110

Advertisement

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

Distribution

Salesforce

AUGUST 4, 2022

For many companies, being seen as trustworthy by customers is an ultimate goal. But what does it really mean to have trust and build trust with customers? In a recent conversation on the Blazing Trails podcast , marketing guru Seth Godin and Salesforce vice president and global innovation evangelist Brian Solis discussed the issues around trust and how companies can get to know their customers better.

Marketing 98

Marketing 98

MedCity News

AUGUST 4, 2022

Pfizer is stopping work on a drug for a rare heart disease after an interim look at Phase 3 data indicated that the study was unlikely to succeed. The small molecule came to Pfizer’s drug pipeline as part of the $11.4 billion acquisition of Array Biopharma in 2019.

Biopharma 110

Biopharma Leads Pharma 110

MedCity News

AUGUST 4, 2022

About 95% of Medicare beneficiaries are anxious about inflation’s impact on healthcare costs, with 45% saying costs have already increased because of inflation, the eHealth survey discovered.

Healthcare 109

Healthcare Healthcare 109

pharmaphorum

AUGUST 4, 2022

Two phase 3 trials of Merck & Co’s Keytruda in metastatic castration-resistant prostate cancer (CRPC) and advanced liver cancer have ended in failure, proving once again that cancer immunotherapy studies can be a hit-and-miss affair. The CRPC trial – KEYNOTE-921 – looked at the combination of Keytruda (pembrolizumab) with docetaxel in more than 1,000 patients who had not been treated with chemotherapy before, but who had seen disease progression despite earlier treatment with an anti-h

Patients 93

Patients FDA 93

MedCity News

AUGUST 4, 2022

NYC Health + Hospitals recently received a $3.9 million grant from Helmsley Charitable Trust to incorporate mental health services into ExpressCare, the health system’s virtual urgent care platform. The health system will also launch a version of its new tele-behavioral health services that is tailored to the New York City’s homeless residents.

108

108

pharmaphorum

AUGUST 4, 2022

Across the economy, several industries have seen a significant increase in staff turnover due to several factors including the COVID-19 pandemic, burnout, and increasing demand for workplace flexibility. This has resulted in staff and talent shortages, meaning that industries have been forced to respond quickly to stay afloat. In particular, for the pharmaceutical industry, these talent shortages bring about a host of difficult challenges.

Recruitment 91

Recruitment Pharma Training Pharmaceutical manufacturing 91

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Safety

MedCity News

AUGUST 4, 2022

Through the collaboration, CareFirst’s individual behavioral health practitioners can join Headway’s platform so members can filter, choose a provider, book and pay in one spot.

Healthcare 100

Healthcare Healthcare 100

pharmaphorum

AUGUST 4, 2022

Ten months after ChemoCentryx scored an unexpected FDA approval for autoimmune disease therapy Tavneos, Amgen has swooped in with a $3.7 billion bid to buy out the company. The $52-per-share offer would give Amgen a drug that some analysts have described as a pipeline in a pill with $1 billion-plus sales potential, and is a sizeable premium on ChemoCentryx’ pre-deal announcement share price of just over $24.

Side effects 83

Side effects Pharma Sales Competition 83

MedCity News

AUGUST 4, 2022

Amgen’s drug portfolio boasts several biologic drugs that are blockbuster sellers. In acquiring ChemoCentryx for $3.7 billion, the pharmaceutical giant gains a company entirely focused on developing small molecule alternatives to biologic medicines.

Medicine 100

Medicine Pharmaceutical Biopharma Pharma 100

Map My Customers

AUGUST 4, 2022

The 2022 Field Sales Benchmark Report is now available! This second annual survey by Map My Customers reveals the state of the field sales profession, trends in sales roles, sales time management, key sales statistics, and how technology impacts the way teams operate. Unlocking the ability to streamline your processes, maximize productivity, and close more deals starts first with understanding how sales professionals operate in their roles.

Sales 76

Sales CRM Prospecting Sales experience 76

Advertisement

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

Specialization

MedCity News

AUGUST 4, 2022

Recognizing the symbiotic relationship between chronic diseases and mental wellbeing highlights a need for common sense solutions that embrace a holistic, more balanced-oriented approach that has proven successful in nature for hundreds of thousands of years.

96

96

PharmExec

AUGUST 4, 2022

Pharma companies may benefit from meeting challenges and embracing small molecule drug discovery.

Pharma 98

Pharma 98

Pharmaceutical Technology

AUGUST 4, 2022

Sinovac Biotech has reported that its Covid-19 vaccine, CoronaVac, obtained approval from the Health Bureau of the Government of the Hong Kong Special Administrative Region of the People's Republic of China for usage in children of the age six months to three years. The consensus interim recommendations on Covid-19 vaccine use in children aged six months or above in Hong Kong were released by the Scientific Committee on Vaccine Preventable Diseases and the Scientific Committee on Emerging and Zo

Specialization 64

Specialization Government Safety Pharmaceutical 64

PharmExec

AUGUST 4, 2022

Better clinical data needed, as well as strategies for tackling opioid abuse, tobacco use, and food safety.

Food 88

Food Safety 88

Advertisement

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

Safety

PharmaTimes

AUGUST 4, 2022

Candidate exhibits a novel mechanism of action and differs considerably from previously approved drugs

87

87

pharmaphorum

AUGUST 4, 2022

Pfizer has stopped development of a drug to treat cardiomyopathy caused by a rare form of heart disease, after it proved ineffective in a phase 3 trial. PF-07265803 – a p38 mitogen-activated protein kinase (MAPK) antagonist also known as emprumapimod – was being tested as a treatment for symptomatic dilated cardiomyopathy (DCM) due to a mutation in the LMNA gene in the REALM-DCM trial.

Biopharma 62

Biopharma Leads Patients Medical 62

Pharmaceutical Technology

AUGUST 4, 2022

Poseida Therapeutics and Roche have signed a strategic partnership and licence agreement to develop allogeneic CAR-T cell therapies for hematologic malignancies. The research and development (R&D) of various present and new ‘off-the-shelf’ cell therapies against targets in B-cell lymphomas, multiple myeloma and other hematologic indications are included in this alliance.

Sales 59

Sales Marketing Pharmaceutical Medicine 59

Clarify Health

AUGUST 4, 2022

Principles of behavioral economics, including inertia, loss aversion, choice overload, and relative social ranking, have been applied to motivate personal health decisions, retirement planning, and savings behavior. However, they have been largely ignored in healthcare, specifically in regard to the design of physician incentive programs. Can behavioral economics be applied in healthcare?

Physicians 52

Physicians Networking Healthcare Healthcare 52

Advertisement

As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.

Management

Pharmaceutical Technology

AUGUST 4, 2022

The health concern over COVID-19 in July 2022 increased averaging at 27.7%, compared to 23.9% recorded in June 2022 , shows the COVID-19 concern index, which is measured by responses to an ongoing poll Verdict launched in March 2020. The poll has been tracking how the concerns over coronavirus have been changing over time. The poll asked how concerned the respondents were about the spread of coronavirus and included five options to choose from - very concerned, slightly concerned, neither concer

Networking 52

Networking Pharmaceutical 52

Clarify Health

AUGUST 4, 2022

Principles of behavioral economics, including inertia, loss aversion, choice overload, and relative social ranking, have been applied to motivate personal health decisions, retirement planning, and savings behavior. However, they have been largely ignored in healthcare, specifically in regard to the design of physician incentive programs. Can behavioral economics be applied in healthcare?

Physicians 52

Physicians Networking Healthcare Healthcare 52

Spotio

AUGUST 4, 2022

B2B sales is different than it was a few years ago. There are more decision-makers for sales reps to meet and touchpoints for them to navigate through than ever before. These things lead to longer sales cycles. The average B2B buyer in 2022 is so much more educated than they would have been in the early 2000s, which further complicating matters. Here are a few stats to prove the complexity of modern B2B sales: There are now an average of 6.8 people involved in every B2B purchase. 74% of B2B bu

B2B Sales 52

B2B Sales Sales Strategy Sales Prospecting 52

Pharmaceutical Technology

AUGUST 4, 2022

Business optimism declined in July 2022 compared to June 2022, amid concerns over inflation as the cost-of-living pressures on households continued to grow in countries such as the UK, revealed the analysis of an ongoing poll by Verdict. Verdict has been conducting the poll to study the trends in business optimism during COVID-19 as reflected by the views of companies on their future growth prospects amid the pandemic.

Prospecting 52

Prospecting Retail Manufacturing Networking 52

Advertisement

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

Leads

PharmaTech

AUGUST 4, 2022

Pharmaceutical Technology spoke with Niamh Lynch, Executive Director, Global Head of Quality, Lonza Small Molecules, Basel about best practices for API quality and the impact of the nitrosamine contamination situation.

Pharmaceutical 52

Pharmaceutical 52

Pharmaceutical Technology

AUGUST 4, 2022

Moderna has reported total revenues of $4.7bn in the second quarter (Q2) of the fiscal year 2022 as against $4.4bn in the year-ago quarter. For the first half (H1) of the year, total revenue stood at $10.8bn, a growth from $6.3bn in the same period in 2021. The revenue growth was attributed to the rise in sales of the company's Covid-19 vaccine. For the three months ended on 30 June 2022, the basic earnings per share (EPS) stood at $5.55, a decline from $6.93 in Q2 last year.

Sales 52

Sales Government Medicine Pharmaceutical 52

Star OUTiCO

AUGUST 4, 2022

The end of July coincided with the conclusion of the Star OUTiCO contribution to the COVID-19 Infection Survey project, and what an incredible contribution we have made. Some of the stats that showcase our efforts are superb, but they only tell some of the story of a project that has grown to a size no one could have imagined when we started during lockdown April 2020.

Recruitment 52

Recruitment Sales Management Consulting Prospecting 52

Pharma Leaders

AUGUST 4, 2022

Denver, CO. – August 2, 2022. Today, Validcare announces the integration of Real-World Research (RWR) Ltd into the Validcare Digital 1 st CRO platform. RWR is a global leader in providing Real-World Evidence solutions to the pharmaceutical, biotech and medical device industries. Dr. Stuart McCully, CEO of RWR said “Until now we’ve provided sponsors with the regulatory intelligence needed to run real-world evidence (RWE) studies.

FDA 52

FDA Management Medical Pharmaceutical 52

Advertisement

The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.

Patients